Connecting you to content on EBSCOhost

Works by Azoulay, M.

Results: 4

1

Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60824-z

By:

Garberis, I.;
Gaury, V.;
Saillard, C.;
Drubay, D.;
Elgui, K.;
Schmauch, B.;
Jaeger, A.;
Herpin, L.;
Linhart, J.;
Sapateiro, M.;
Bernigole, F.;
Kamoun, A.;
Filiot, A.;
Tchita, O.;
Dubois, R.;
Auffret, M.;
Guillou, L.;
Bousaid, I.;
Azoulay, M.;
Lemonnier, J.

Publication type:

Article

2

Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 3, p. 419, doi. 10.1007/s11060-017-2383-2

By:

Azoulay, M.;
Santos, F.;
Shenouda, G.;
Petrecca, K.;
Oweida, A.;
Guiot, M.;
Owen, S.;
Panet-Raymond, V.;
Souhami, L.;
Abdulkarim, Bassam

Publication type:

Article

3

Petits meurtres en famille.

Published in:

European Psychiatry, 2015, v. 30, n. 8, p. S60, doi. 10.1016/j.eurpsy.2015.09.167

By:

Azoulay, M.;
Delbreil, A.;
Raymond, S.;
Zagury, D.

Publication type:

Article

4

S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL.

Published in:

HemaSphere, 2022, v. 6, p. 109, doi. 10.1097/01.HS9.0000843724.38671.cf

By:

Zelenetz, A.;
Jurczak, W.;
Ribrag, V.;
Linton, K.;
Collins, G.;
Lopéz‐Jiménez, J.;
Reddy, N.;
Mengarelli, A.;
Phillips, T.;
Musuraca, G.;
Sheehy, O.;
Li, J.;
Xu, W.;
Azoulay, M.;
Ghalie, R.;
Zinzani, P. L.

Publication type:

Article